Copyright Reports & Markets. All rights reserved.

Global Helicobacter Pylori Diagnostics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Helicobacter Pylori Diagnostics Market Overview

    • 1.1 Product Overview and Scope of Helicobacter Pylori Diagnostics
    • 1.2 Classification of Helicobacter Pylori Diagnostics by Types
      • 1.2.1 Global Helicobacter Pylori Diagnostics Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Helicobacter Pylori Diagnostics Revenue Market Share by Types in 2018
      • 1.2.3 Invasive Techniques
      • 1.2.4 Non-invasive Techniques
    • 1.3 Global Helicobacter Pylori Diagnostics Market by Application
      • 1.3.1 Global Helicobacter Pylori Diagnostics Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospitals and Clinics
      • 1.3.3 Diagnostic Laboratories
    • 1.4 Global Helicobacter Pylori Diagnostics Market by Regions
      • 1.4.1 Global Helicobacter Pylori Diagnostics Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Helicobacter Pylori Diagnostics Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Helicobacter Pylori Diagnostics Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Helicobacter Pylori Diagnostics Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Helicobacter Pylori Diagnostics Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Helicobacter Pylori Diagnostics Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Helicobacter Pylori Diagnostics (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Sekisui Diagnostics
      • 2.1.1 Business Overview
      • 2.1.2 Helicobacter Pylori Diagnostics Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 F. Hoffmann-La Roche
      • 2.2.1 Business Overview
      • 2.2.2 Helicobacter Pylori Diagnostics Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Medline Industries
      • 2.3.1 Business Overview
      • 2.3.2 Helicobacter Pylori Diagnostics Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Medline Industries Helicobacter Pylori Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Meridian Bioscience
      • 2.4.1 Business Overview
      • 2.4.2 Helicobacter Pylori Diagnostics Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Meridian Bioscience Helicobacter Pylori Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Bio-Rad Laboratories
      • 2.5.1 Business Overview
      • 2.5.2 Helicobacter Pylori Diagnostics Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Thermo Fisher Scientific
      • 2.6.1 Business Overview
      • 2.6.2 Helicobacter Pylori Diagnostics Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Alpha Laboratories
      • 2.7.1 Business Overview
      • 2.7.2 Helicobacter Pylori Diagnostics Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Alpha Laboratories Helicobacter Pylori Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 EKF Diagnostics
      • 2.8.1 Business Overview
      • 2.8.2 Helicobacter Pylori Diagnostics Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 EKF Diagnostics Helicobacter Pylori Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Quidel
      • 2.9.1 Business Overview
      • 2.9.2 Helicobacter Pylori Diagnostics Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Quidel Helicobacter Pylori Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Halyard Health, Inc
      • 2.10.1 Business Overview
      • 2.10.2 Helicobacter Pylori Diagnostics Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Halyard Health, Inc Helicobacter Pylori Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Cardinal Health
      • 2.11.1 Business Overview
      • 2.11.2 Helicobacter Pylori Diagnostics Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Cardinal Health Helicobacter Pylori Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Beckman Coulter Inc
      • 2.12.1 Business Overview
      • 2.12.2 Helicobacter Pylori Diagnostics Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Beckman Coulter Inc Helicobacter Pylori Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Agilent Technologies
      • 2.13.1 Business Overview
      • 2.13.2 Helicobacter Pylori Diagnostics Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Agilent Technologies Helicobacter Pylori Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Coris BioConcept
      • 2.14.1 Business Overview
      • 2.14.2 Helicobacter Pylori Diagnostics Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Coris BioConcept Helicobacter Pylori Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Helicobacter Pylori Diagnostics Market Competition, by Players

    • 3.1 Global Helicobacter Pylori Diagnostics Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Helicobacter Pylori Diagnostics Players Market Share
      • 3.2.2 Top 10 Helicobacter Pylori Diagnostics Players Market Share
    • 3.3 Market Competition Trend

    4 Global Helicobacter Pylori Diagnostics Market Size by Regions

    • 4.1 Global Helicobacter Pylori Diagnostics Revenue and Market Share by Regions
    • 4.2 North America Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 4.5 South America Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)

    5 North America Helicobacter Pylori Diagnostics Revenue by Countries

    • 5.1 North America Helicobacter Pylori Diagnostics Revenue by Countries (2014-2019)
    • 5.2 USA Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)

    6 Europe Helicobacter Pylori Diagnostics Revenue by Countries

    • 6.1 Europe Helicobacter Pylori Diagnostics Revenue by Countries (2014-2019)
    • 6.2 Germany Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 6.3 UK Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 6.4 France Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Helicobacter Pylori Diagnostics Revenue by Countries

    • 7.1 Asia-Pacific Helicobacter Pylori Diagnostics Revenue by Countries (2014-2019)
    • 7.2 China Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 7.5 India Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)

    8 South America Helicobacter Pylori Diagnostics Revenue by Countries

    • 8.1 South America Helicobacter Pylori Diagnostics Revenue by Countries (2014-2019)
    • 8.2 Brazil Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Helicobacter Pylori Diagnostics by Countries

    • 9.1 Middle East and Africa Helicobacter Pylori Diagnostics Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Helicobacter Pylori Diagnostics Revenue and Growth Rate (2014-2019)

    10 Global Helicobacter Pylori Diagnostics Market Segment by Type

    • 10.1 Global Helicobacter Pylori Diagnostics Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Helicobacter Pylori Diagnostics Market Forecast by Type (2019-2024)
    • 10.3 Invasive Techniques Revenue Growth Rate (2014-2024)
    • 10.4 Non-invasive Techniques Revenue Growth Rate (2014-2024)

    11 Global Helicobacter Pylori Diagnostics Market Segment by Application

    • 11.1 Global Helicobacter Pylori Diagnostics Revenue Market Share by Application (2014-2019)
    • 11.2 Helicobacter Pylori Diagnostics Market Forecast by Application (2019-2024)
    • 11.3 Hospitals and Clinics Revenue Growth (2014-2019)
    • 11.4 Diagnostic Laboratories Revenue Growth (2014-2019)

    12 Global Helicobacter Pylori Diagnostics Market Size Forecast (2019-2024)

    • 12.1 Global Helicobacter Pylori Diagnostics Market Size Forecast (2019-2024)
    • 12.2 Global Helicobacter Pylori Diagnostics Market Forecast by Regions (2019-2024)
    • 12.3 North America Helicobacter Pylori Diagnostics Revenue Market Forecast (2019-2024)
    • 12.4 Europe Helicobacter Pylori Diagnostics Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Helicobacter Pylori Diagnostics Revenue Market Forecast (2019-2024)
    • 12.6 South America Helicobacter Pylori Diagnostics Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Helicobacter Pylori Diagnostics Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations.

      Scope of the Report:
      One of the key drivers witnessed in the market is the growing cost-effectiveness of diagnosis and personalized antibiotic therapy. H. pylori bacteria causes ulcer. H. pylori infection requires antibiotic therapy that includes 10-14 days treatment regimen. This treatment regimen comprises of one or two antibiotics such as amoxicillin, tetracycline, metronidazole, or clarithromycin in combination with ranitidine bismuth citrate, bismuth subsalicylate, and a proton pump inhibitor (PPI). Ulcer-related symptoms such as abdominal pain and nausea and inflammation of gastric mucosa can be cured using PPIs or H2 blockers in combination with antibiotics. The cost-effectiveness of antibiotics and the lesser duration of treatment boosts the adoption of antibiotic regimen by healthcare professionals. This in turn, will drive the demand for pre- and post-monitoring tests.

      In terms of geography, the Europe accounted for the majority market shares during 2017 and this mainly accounted to the growing prevalence of peptic ulcer disease and gastritis. The increasing patient pool looking for the early detection of symptoms and treatment is boosting the demand for helicobacter pylori diagnostics in the region. Owing to the continuous efforts of vendors to develop a vaccination for H. pylori infection and the introduction of improved diagnostic techniques, the market will continue to witness considerable growth in this region during the next four years as well.

      The helicobacter pylori diagnostics market is characterized by the presence of major vendors and is highly competitive. These vendors compete against each other based on factors including pricing, product differentiation, and advancements in technology. Vendors are highly focusing on expanding their product portfolio and increasing investments in acquiring other players, which will help them increase their revenue shares. Additionally, they are also focusing on the development of vaccines and enhancing their presence in the regional and untapped markets.

      Hospitals and clinics reduce the overall disease burden and promote health by offering immunoassays and molecular diagnostic techniques. These techniques enable the early diagnosis of infectious and lethal diseases. The patient pool suffering from infectious diseases such as bacterial diseases (enteric bacteria), cancer, and other life-threatening diseases highly rely on hospitals since they have tie-ups with research and developmental centers and research institutes.

      The global Helicobacter Pylori Diagnostics market is valued at 480 million USD in 2018 and is expected to reach 740 million USD by the end of 2024, growing at a CAGR of 7.6% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Helicobacter Pylori Diagnostics.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Helicobacter Pylori Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Helicobacter Pylori Diagnostics market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Sekisui Diagnostics
      F. Hoffmann-La Roche
      Medline Industries
      Meridian Bioscience
      Bio-Rad Laboratories
      Thermo Fisher Scientific
      Alpha Laboratories
      EKF Diagnostics
      Quidel
      Halyard Health, Inc
      Cardinal Health
      Beckman Coulter Inc
      Agilent Technologies
      Coris BioConcept

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Invasive Techniques
      Non-invasive Techniques

      Market Segment by Applications, can be divided into
      Hospitals and Clinics
      Diagnostic Laboratories

      Buy now